Report of Foreign Issuer (6-k)
14 Août 2020 - 1:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE
SECURITIES EXCHANGE ACT OF 1934
For the month of August 2020
Commission File Number 001-37652
Midatech Pharma PLC
(Translation of registrant’s name
into English)
Oddfellows House,
19 Newport Road,
Cardiff, CF24 0AA, United Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F x Form
40-F ¨
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
This Report on Form 6-K, including Exhibit 99.1, is
hereby incorporated by reference into the Company’s Registration Statement on Form F-3 (File No. 333-233901).
SUBMITTED HEREWITH
Attached to the Registrant’s Form 6-K filing for the month
of August 2020, and incorporated by reference herein, is:
|
Exhibit No.
|
|
Description
|
|
|
|
|
99.1
|
|
Press release, dated August 14, 2020 entitled
“Registration Statement on Form F-1 Declared Effective, May 2020 UK Warrants Now Exercisable”
|
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Midatech Pharma PLC
|
|
|
|
|
|
|
|
|
|
|
|
Date: August 14, 2020
|
|
|
|
By:
|
|
/s/ Stephen Stamp
|
|
|
|
|
|
|
|
|
|
Stephen Stamp
Chief Executive Officer, Chief Financial
Officer
|
Exhibit Index
|
Exhibit No.
|
|
Description
|
|
|
|
|
99.1
|
|
Press release, dated August 14, 2020 entitled
“Registration Statement on Form F-1 Declared Effective, May 2020 UK Warrants Now Exercisable”
|
Midatech Pharma (NASDAQ:MTP)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Midatech Pharma (NASDAQ:MTP)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
